ZA200603347B - Superoxide dismutase mimics for the treatment of optic nerve and retinal damage - Google Patents
Superoxide dismutase mimics for the treatment of optic nerve and retinal damageInfo
- Publication number
- ZA200603347B ZA200603347B ZA200603347A ZA200603347A ZA200603347B ZA 200603347 B ZA200603347 B ZA 200603347B ZA 200603347 A ZA200603347 A ZA 200603347A ZA 200603347 A ZA200603347 A ZA 200603347A ZA 200603347 B ZA200603347 B ZA 200603347B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- superoxide dismutase
- optic nerve
- retinal damage
- dismutase mimics
- Prior art date
Links
- 206010057430 Retinal injury Diseases 0.000 title 1
- 102000019197 Superoxide Dismutase Human genes 0.000 title 1
- 108010012715 Superoxide dismutase Proteins 0.000 title 1
- 210000001328 optic nerve Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52883003P | 2003-12-11 | 2003-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200603347B true ZA200603347B (en) | 2009-02-25 |
Family
ID=34710102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200603347A ZA200603347B (en) | 2003-12-11 | 2004-11-30 | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20070060557A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1691815A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007513948A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060101501A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1889961A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004305531B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417549A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2545762A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06006187A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006124746A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005060974A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200603347B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
| KR100724586B1 (ko) | 2005-12-09 | 2007-06-04 | 세종대학교산학협력단 | 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물 |
| US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
| US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
| US20190388548A1 (en) * | 2018-06-26 | 2019-12-26 | Tzu Chi University | Method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550022A (en) * | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| DE3773926D1 (de) * | 1987-07-22 | 1991-11-21 | Farvalsa Ag | Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung. |
| US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
| SE9402816D0 (sv) * | 1994-08-24 | 1994-08-24 | Pharmacia Ab | Method and meams for drug administration |
| US6180620B1 (en) * | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| US6214817B1 (en) * | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| AU5251999A (en) | 1998-08-04 | 2000-02-28 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
| GB9817845D0 (en) * | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
| WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
| ES2240101T3 (es) | 1999-05-27 | 2005-10-16 | Monsanto Company | Biomateriales modificados con mimeticos de superoxido dismutasa. |
| DE60231246D1 (de) * | 2001-12-14 | 2009-04-02 | Alcon Inc | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen |
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
-
2004
- 2004-11-30 CN CNA2004800367477A patent/CN1889961A/zh active Pending
- 2004-11-30 RU RU2006124746/14A patent/RU2006124746A/ru not_active Application Discontinuation
- 2004-11-30 EP EP04812365A patent/EP1691815A4/en not_active Withdrawn
- 2004-11-30 BR BRPI0417549-2A patent/BRPI0417549A/pt not_active IP Right Cessation
- 2004-11-30 KR KR1020067010078A patent/KR20060101501A/ko not_active Ceased
- 2004-11-30 MX MXPA06006187A patent/MXPA06006187A/es unknown
- 2004-11-30 JP JP2006543859A patent/JP2007513948A/ja active Pending
- 2004-11-30 US US10/575,911 patent/US20070060557A1/en not_active Abandoned
- 2004-11-30 WO PCT/US2004/039830 patent/WO2005060974A1/en not_active Ceased
- 2004-11-30 US US11/000,213 patent/US20050130951A1/en not_active Abandoned
- 2004-11-30 CA CA002545762A patent/CA2545762A1/en not_active Abandoned
- 2004-11-30 AU AU2004305531A patent/AU2004305531B2/en not_active Ceased
- 2004-11-30 ZA ZA200603347A patent/ZA200603347B/xx unknown
-
2010
- 2010-12-17 US US12/971,143 patent/US20110105453A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004305531A1 (en) | 2005-07-07 |
| WO2005060974A1 (en) | 2005-07-07 |
| AU2004305531B2 (en) | 2009-11-26 |
| EP1691815A4 (en) | 2010-03-31 |
| US20070060557A1 (en) | 2007-03-15 |
| US20110105453A1 (en) | 2011-05-05 |
| US20050130951A1 (en) | 2005-06-16 |
| CN1889961A (zh) | 2007-01-03 |
| MXPA06006187A (es) | 2006-08-25 |
| CA2545762A1 (en) | 2005-07-07 |
| EP1691815A1 (en) | 2006-08-23 |
| KR20060101501A (ko) | 2006-09-25 |
| RU2006124746A (ru) | 2008-01-20 |
| JP2007513948A (ja) | 2007-05-31 |
| BRPI0417549A (pt) | 2007-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1581212A4 (en) | SUPEROXIDE DISMUTASE IMITATIONS FOR THE TREATMENT OF EYE DISORDERS AND DISEASES | |
| IL291162A (en) | Isolated human rpe cells and their use for the treatment of retinal degenerative diseases | |
| TWI369996B (en) | Ophthalmic compositions and methods for treating eyes | |
| EP1592435A4 (en) | EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS | |
| GB0404693D0 (en) | Pharmaceutical preparations for the treatment of ocular surface and other disorders | |
| IL178142A0 (en) | Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders | |
| HUE063927T2 (hu) | Szemallergiák kezelésében alkalmazott eljárások és szemészeti eszközök | |
| MX301561B (en) | Use of transmission dyes for protecting human skin from browning and ageing | |
| PL1641915T3 (pl) | Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo | |
| FI20010898A0 (fi) | Ekstrasellulaarinen superoksididismutaasi (EC-SOD) geeniterapia restenoosoin ehkäisemiseksi | |
| EP1708757A4 (en) | USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE | |
| PL371281A1 (en) | Methods and compositions for the treatment of eye diseases | |
| EP1812077A4 (en) | MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING A FIBROSIS-ASSOCIATED DISEASE | |
| SI1884234T1 (sl) | Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo | |
| AU2003272204A8 (en) | Neuronal and retinal gene expression patterns | |
| IL176227A0 (en) | Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases | |
| EP1691815A4 (en) | SUPEROXIDE DISMUTASE MIMETICS FOR THE TREATMENT OF OPTIC AND RETINA DAMAGE | |
| AU2003243405A1 (en) | Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain | |
| HK1095516A (en) | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage | |
| PL1812797T3 (pl) | Kompozycje i sposoby do leczenia chorób hiperproliferacyjnych i zapobiegania tym chorobom | |
| HK1084315A (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| HK1087612A (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| GB0523964D0 (en) | The treatment of ophthalmic diseases | |
| AU2003240254A1 (en) | Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac | |
| PT1706094T (pt) | Tratamento de condições oftalmológicas |